RXST logo

RxSight (RXST) Cash From Financing

Annual CFF

$123.32 M
+$61.80 M+100.44%

December 31, 2024


Summary


Performance

RXST Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXSTcash flowmetrics:

Quarterly CFF

$2.98 M
+$2.10 M+238.95%

December 31, 2024


Summary


Performance

RXST Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXSTcash flowmetrics:

TTM CFF

$123.32 M
-$586.00 K-0.47%

December 31, 2024


Summary


Performance

RXST TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRXSTcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

RXST Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.4%0.0%0.0%
3 y3 years-10.2%0.0%0.0%
5 y5 years+9172.1%0.0%0.0%

RXST Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.2%+1847.5%-97.3%+136.1%-10.2%>+9999.0%
5 y5-year-10.2%+9172.1%-97.5%+136.1%-23.5%>+9999.0%
alltimeall time-10.2%+9172.1%-97.5%+136.1%-23.5%>+9999.0%

RxSight Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$123.32 M(+100.4%)
$2.98 M(+239.0%)
$123.32 M(-0.5%)
Sep 2024
-
$878.00 K(-99.2%)
$123.91 M(+7.9%)
Jun 2024
-
$111.47 M(+1294.8%)
$114.79 M(+2626.0%)
Mar 2024
-
$7.99 M(+124.4%)
$4.21 M(-93.2%)
Dec 2023
$61.52 M(+871.6%)
$3.56 M(-143.3%)
$61.52 M(-4.3%)
Sep 2023
-
-$8.23 M(-1024.1%)
$64.27 M(-10.8%)
Jun 2023
-
$891.00 K(-98.6%)
$72.05 M(+0.4%)
Mar 2023
-
$65.31 M(+935.4%)
$71.73 M(+1032.9%)
Dec 2022
$6.33 M
$6.31 M(-1486.2%)
$6.33 M(+1376.0%)
Sep 2022
-
-$455.00 K(-178.7%)
$429.00 K(-99.6%)
DateAnnualQuarterlyTTM
Jun 2022
-
$578.00 K(-689.8%)
$121.43 M(-7.4%)
Mar 2022
-
-$98.00 K(-124.3%)
$131.10 M(-4.5%)
Dec 2021
$137.34 M(+444.2%)
$404.00 K(-99.7%)
$137.34 M(-14.8%)
Sep 2021
-
$120.55 M(+1076.4%)
$161.27 M(+295.5%)
Jun 2021
-
$10.25 M(+66.8%)
$40.77 M(+30.2%)
Mar 2021
-
$6.14 M(-74.7%)
$31.31 M(+24.0%)
Dec 2020
$25.24 M(+1797.5%)
$24.33 M(>+9900.0%)
$25.24 M(+2676.3%)
Sep 2020
-
$52.00 K(-93.4%)
$909.00 K(+6.1%)
Jun 2020
-
$782.00 K(+942.7%)
$857.00 K(+1042.7%)
Mar 2020
-
$75.00 K
$75.00 K
Dec 2019
$1.33 M
-
-

FAQ

  • What is RxSight annual cash flow from financing activities?
  • What is the all time high annual CFF for RxSight?
  • What is RxSight annual CFF year-on-year change?
  • What is RxSight quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for RxSight?
  • What is RxSight quarterly CFF year-on-year change?
  • What is RxSight TTM cash flow from financing activities?
  • What is the all time high TTM CFF for RxSight?
  • What is RxSight TTM CFF year-on-year change?

What is RxSight annual cash flow from financing activities?

The current annual CFF of RXST is $123.32 M

What is the all time high annual CFF for RxSight?

RxSight all-time high annual cash flow from financing activities is $137.34 M

What is RxSight annual CFF year-on-year change?

Over the past year, RXST annual cash flow from financing activities has changed by +$61.80 M (+100.44%)

What is RxSight quarterly cash flow from financing activities?

The current quarterly CFF of RXST is $2.98 M

What is the all time high quarterly CFF for RxSight?

RxSight all-time high quarterly cash flow from financing activities is $120.55 M

What is RxSight quarterly CFF year-on-year change?

Over the past year, RXST quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is RxSight TTM cash flow from financing activities?

The current TTM CFF of RXST is $123.32 M

What is the all time high TTM CFF for RxSight?

RxSight all-time high TTM cash flow from financing activities is $161.27 M

What is RxSight TTM CFF year-on-year change?

Over the past year, RXST TTM cash flow from financing activities has changed by $0.00 (0.00%)